retatrutide phase 2 trial type 2 diabetes weight loss 2024 Retatrutide, an experimental weight-loss drug VisualAbstract: Retatrutide reduces body weight

Effective Dosages and Safety Finding the right dosage is essential for maximising benefits while minimising potential side effects

289 CSCs do not exist in isolation

Rehfeld, Jan Fahrenkrug, Jens Holst, Thue Schwartz, Peter Horness, Claus Khl and Ove Schaffalitzky de Muckadell

The drug class evolved through iteration, not revolution: GLP-1 Drug Class Evolution twice-daily injections once-weekly dosing entered popular culture Cultural moment dual GLP-1 + GIP agonist More potent + glucagon receptor Coming Each generation solved a limitation of the one before it, a drug class earning clinical confidence incrementally over two decades of real-world use